Feola, T.; Carbonara, F.; Verrico, M.; Di Crescenzo, R.M.; Gianno, F.; Colonnese, C.; Arcella, A.; de Alcubierre, D.; Tomao, S.; Esposito, V.;
et al. Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art. Cancers 2022, 14, 4093.
https://doi.org/10.3390/cancers14174093
AMA Style
Feola T, Carbonara F, Verrico M, Di Crescenzo RM, Gianno F, Colonnese C, Arcella A, de Alcubierre D, Tomao S, Esposito V,
et al. Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art. Cancers. 2022; 14(17):4093.
https://doi.org/10.3390/cancers14174093
Chicago/Turabian Style
Feola, Tiziana, Francesca Carbonara, Monica Verrico, Rosa Maria Di Crescenzo, Francesca Gianno, Claudio Colonnese, Antonietta Arcella, Dario de Alcubierre, Silverio Tomao, Vincenzo Esposito,
and et al. 2022. "Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art" Cancers 14, no. 17: 4093.
https://doi.org/10.3390/cancers14174093
APA Style
Feola, T., Carbonara, F., Verrico, M., Di Crescenzo, R. M., Gianno, F., Colonnese, C., Arcella, A., de Alcubierre, D., Tomao, S., Esposito, V., Giangaspero, F., Minniti, G., & Jaffrain-Rea, M.-L.
(2022). Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art. Cancers, 14(17), 4093.
https://doi.org/10.3390/cancers14174093
